EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/37/d6/d6/37d6d63a-dbc7-822d-5311-09600bb24999/mza_4998781875777479771.jpg/600x600bb.jpg

The Genetics Podcast

Sano Genetics

192 episodes

2 days ago

Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com

Natural Sciences

Science

RSS

All content for The Genetics Podcast is the property of Sano Genetics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Natural Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/42937126/b306bb0717f71df9.png

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

The Genetics Podcast

53 minutes 4 seconds

4 months ago

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

In this episode, we’re joined by Dr. Ness Bermingham, Operating Partner at Khosla Ventures and Chair of the Board at Korro Bio. A scientist-turned-biotech entrepreneur, Ness is passionate about the power of science to tackle some of healthcare’s biggest challenges. Ness co-founded Intellia Therapeutics, a leader in CRISPR gene editing, and Korro Bio, an innovator in RNA editing, driving breakthroughs that translate cutting-edge science into real healthcare solutions. With over 20 years of experience in biotech and healthcare, he’s played a vital role in shaping startups into companies that develop life-changing medicines. Tune in as we dive into Ness’s journey and his insights on innovation in biotech!